229 related articles for article (PubMed ID: 26507663)
1. Unmasking of CD22 Co-receptor on Germinal Center B-cells Occurs by Alternative Mechanisms in Mouse and Man.
Macauley MS; Kawasaki N; Peng W; Wang SH; He Y; Arlian BM; McBride R; Kannagi R; Khoo KH; Paulson JC
J Biol Chem; 2015 Dec; 290(50):30066-77. PubMed ID: 26507663
[TBL] [Abstract][Full Text] [Related]
2. CD22 Controls Germinal Center B Cell Receptor Signaling, Which Influences Plasma Cell and Memory B Cell Output.
Meyer SJ; Steffensen M; Acs A; Weisenburger T; Wadewitz C; Winkler TH; Nitschke L
J Immunol; 2021 Aug; 207(4):1018-1032. PubMed ID: 34330755
[TBL] [Abstract][Full Text] [Related]
3. Coordinated changes in glycosylation regulate the germinal center through CD22.
Enterina JR; Sarkar S; Streith L; Jung J; Arlian BM; Meyer SJ; Takematsu H; Xiao C; Baldwin TA; Nitschke L; Shlomchick MJ; Paulson JC; Macauley MS
Cell Rep; 2022 Mar; 38(11):110512. PubMed ID: 35294874
[TBL] [Abstract][Full Text] [Related]
4. Proximity labeling of cis-ligands of CD22/Siglec-2 reveals stepwise α2,6 sialic acid-dependent and -independent interactions.
Alborzian Deh Sheikh A; Akatsu C; Imamura A; Abdu-Allah HHM; Takematsu H; Ando H; Ishida H; Tsubata T
Biochem Biophys Res Commun; 2018 Jan; 495(1):854-859. PubMed ID: 29146181
[TBL] [Abstract][Full Text] [Related]
5. Functional evaluation of activation-dependent alterations in the sialoglycan composition of T cells.
Naito-Matsui Y; Takada S; Kano Y; Iyoda T; Sugai M; Shimizu A; Inaba K; Nitschke L; Tsubata T; Oka S; Kozutsumi Y; Takematsu H
J Biol Chem; 2014 Jan; 289(3):1564-79. PubMed ID: 24297165
[TBL] [Abstract][Full Text] [Related]
6. High-affinity ligand probes of CD22 overcome the threshold set by cis ligands to allow for binding, endocytosis, and killing of B cells.
Collins BE; Blixt O; Han S; Duong B; Li H; Nathan JK; Bovin N; Paulson JC
J Immunol; 2006 Sep; 177(5):2994-3003. PubMed ID: 16920935
[TBL] [Abstract][Full Text] [Related]
7. Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation.
Naito Y; Takematsu H; Koyama S; Miyake S; Yamamoto H; Fujinawa R; Sugai M; Okuno Y; Tsujimoto G; Yamaji T; Hashimoto Y; Itohara S; Kawasaki T; Suzuki A; Kozutsumi Y
Mol Cell Biol; 2007 Apr; 27(8):3008-22. PubMed ID: 17296732
[TBL] [Abstract][Full Text] [Related]
8. Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking.
Han S; Collins BE; Bengtson P; Paulson JC
Nat Chem Biol; 2005 Jul; 1(2):93-7. PubMed ID: 16408005
[TBL] [Abstract][Full Text] [Related]
9. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.
Matsubara N; Imamura A; Yonemizu T; Akatsu C; Yang H; Ueki A; Watanabe N; Abdu-Allah H; Numoto N; Takematsu H; Kitazume S; Tedder TF; Marth JD; Ito N; Ando H; Ishida H; Kiso M; Tsubata T
Front Immunol; 2018; 9():820. PubMed ID: 29725338
[TBL] [Abstract][Full Text] [Related]
10. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes.
Razi N; Varki A
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7469-74. PubMed ID: 9636173
[TBL] [Abstract][Full Text] [Related]
11. CD22 is required for formation of memory B cell precursors within germinal centers.
Chappell CP; Draves KE; Clark EA
PLoS One; 2017; 12(3):e0174661. PubMed ID: 28346517
[TBL] [Abstract][Full Text] [Related]
12. Coordinated roles for glycans in regulating the inhibitory function of CD22 on B cells.
Enterina JR; Jung J; Macauley MS
Biomed J; 2019 Aug; 42(4):218-232. PubMed ID: 31627864
[TBL] [Abstract][Full Text] [Related]
13. Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2.
Kimura N; Ohmori K; Miyazaki K; Izawa M; Matsuzaki Y; Yasuda Y; Takematsu H; Kozutsumi Y; Moriyama A; Kannagi R
J Biol Chem; 2007 Nov; 282(44):32200-7. PubMed ID: 17728258
[TBL] [Abstract][Full Text] [Related]
14. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
Meyer SJ; Linder AT; Brandl C; Nitschke L
Front Immunol; 2018; 9():2820. PubMed ID: 30559744
[TBL] [Abstract][Full Text] [Related]
15. Loss of N-glycolylneuraminic acid in human evolution. Implications for sialic acid recognition by siglecs.
Brinkman-Van der Linden EC; Sjoberg ER; Juneja LR; Crocker PR; Varki N; Varki A
J Biol Chem; 2000 Mar; 275(12):8633-40. PubMed ID: 10722703
[TBL] [Abstract][Full Text] [Related]
16. A structure-function study of ligand recognition by CD22beta.
van Rossenberg SM; Sliedregt LA; Autar R; Piperi C; Van Der Merwe AP; van Berkel TJ; Kuiper J; Biessen EA
J Biol Chem; 2001 Apr; 276(16):12967-73. PubMed ID: 11152460
[TBL] [Abstract][Full Text] [Related]
17. Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans.
Giovannone N; Liang J; Antonopoulos A; Geddes Sweeney J; King SL; Pochebit SM; Bhattacharyya N; Lee GS; Dell A; Widlund HR; Haslam SM; Dimitroff CJ
Nat Commun; 2018 Aug; 9(1):3287. PubMed ID: 30120234
[TBL] [Abstract][Full Text] [Related]
18. Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.
Spiller F; Nycholat CM; Kikuchi C; Paulson JC; Macauley MS
J Immunol; 2018 Feb; 200(3):949-956. PubMed ID: 29288201
[TBL] [Abstract][Full Text] [Related]
19. The oligosaccharide binding specificities of CD22 beta, a sialic acid-specific lectin of B cells.
Powell LD; Varki A
J Biol Chem; 1994 Apr; 269(14):10628-36. PubMed ID: 8144652
[TBL] [Abstract][Full Text] [Related]
20. In situ trans ligands of CD22 identified by glycan-protein photocross-linking-enabled proteomics.
Ramya TN; Weerapana E; Liao L; Zeng Y; Tateno H; Liao L; Yates JR; Cravatt BF; Paulson JC
Mol Cell Proteomics; 2010 Jun; 9(6):1339-51. PubMed ID: 20172905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
